- ►chestpubs.org HR Büller, G Agnelli, RD Hull, TM Hyers, MH Prins, … - Chest, 2004 - chestjournal.chestpubs.org This chapter about antithrombotic therapy for venous thromboembolic disease is part of the seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based
Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do ... Cited by 937 - Related articles - BL Direct - All 9 versions
SM Bates, IA Greer, J Hirsh, JS Ginsberg - Chest, 2004 - Am Coll Chest Phys This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh ACCP
Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade
1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, ... Cited by 410 - Related articles - BL Direct - All 13 versions
LR Dolovich, JS Ginsberg, JD Douketis, AM … - Archives of Internal …, 2000 - Am Med Assoc Results Thirteen studies were included. There was no statistically significant difference in risk
between UFH and LMWHs for recurrent VTE (RR, 0.85 [95% CI, 0.65-1.12]), pulmonary embolism
(RR, 1.02 [95% CI, 0.64-1.62]), major bleeding (RR, 0.63 [95% CI, 0.37-1.05]), minor ... Cited by 400 - Related articles - BL Direct - All 5 versions
JS Ginsberg - New England Journal of Medicine, 1996 - content.nejm.org Venous thromboembolism, which includes deep-vein thrombosis (usually involving leg
veins) and pulmonary embolism, is a common cause of death. Treatment of affected patients
reduces the incidence of fatal pulmonary embolism, but therapy should be based on the ... Cited by 303 - Related articles - All 5 versions
- ►bloodjournal.org [PDF] P Salven, S Mustjoki, R Alitalo, K Alitalo, S Rafii - Blood, 2002 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ... Cited by 238 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org [PDF] DB Brieger, KH Mak, K Kottke-Marchant, EJ Topol - Journal of the American …, 1998 - Elsevier Heparin-induced thrombocytopenia (HIT) is a potentially serious complication of heparin therapy
and is being encountered more frequently in patients with cardiovascular disease as use of anticoagulant
therapy becomes more widespread. Our understanding of the pathophysiology of this ... Cited by 168 - Related articles - BL Direct - All 9 versions
M Laposata, D Green, EM Van Cott, TW Barrowcliffe, … - Arch Pathol Lab Med, 1998 - cap.org Page 1. Arch Pathol Lab Med—Vol 122, September 1998 Use and Monitoring of
Low-Molecular-Weight Heparin—Laposata et al 799 College of American Pathologists
Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy ... Cited by 132 - Related articles - View as HTML - BL Direct - All 6 versions
- ►chestjournal.org B Tardy-Poncet, B Tardy, J Reynaud, P Mahul, P … - Chest, 1999 - Am Coll Chest Phys Results: Among the 26 patients treated with therapeutic doses, neither new thrombotic complications
nor thrombosis extension was clinically suspected. Two deaths were directly related to lower
limb acute arterial thrombosis associated with HIT. Two major hemorrhagic complications ... Cited by 74 - Related articles - BL Direct - All 7 versions
- ►bloodjournal.org SM Bates, JS Ginsberg - Blood, 2002 - Am Soc Hematology The management of venous thromboembolism (VTE) in pregnancy is challenging for several
reasons. Many diagnostic tests are less accurate in pregnant than in nonpregnant patients, and
some of the radiologic procedures utilized are potentially hazardous to the fetus. When ... Cited by 73 - Related articles - BL Direct - All 8 versions
BM Alving - Blood, 2003 - bloodjournal.hematologylibrary.org Heparin-induced thrombocytopenia (HIT) is one of the most common and potentially devastating
of immune-mediated drug reactions. 1 The clinical manifestations of this disorder are initiated
by antibodies directed against platelet factor 4 (PF4), which becomes an antigenic target ... Cited by 72 - Related articles - BL Direct - All 8 versions
